Solaris Vaccines
Fort Collins, US · Founded 2021 · Delaware corporation
Founders & leadership
RC
Robert Calvin GoforthDirector
MA
Michael ArtingerExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$110KraisedMay 2023 · 3 investors · OtherRule 506(b)
▶$110KraisedMay 2023 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Michael ArtingerExecutive Officer, Director
- Robert Calvin GoforthDirector
- Offering amount
- $200K
- Amount sold
- $110K
- Minimum investment
- $10K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$500KraisedJan 2022 · 1 investors · OtherRule 506(b)
▶$500KraisedJan 2022 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Robert Calvin GoforthDirector
- Michael ArtingerExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $298.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.